About Gilead Sciences, Inc (GILD)

Company Description:

Gilead Sciences, Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative medicines in areas of unmet medical needs. The company's primary areas of focus include HIV/AIDS, liver diseases, hematology and oncology, inflammatory and respiratory diseases, and cardiovascular conditions.

Gilead Sciences was founded in June 1987 by Michael L. Riordan and is headquartered in Foster City, California, United States.

Main Product(s):

Gilead Sciences is known for its antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including notable drugs like Truvada, Harvoni, and Sovaldi. The company has also been involved in the development and distribution of Remdesivir, a treatment for COVID-19.

Short History of Gilead Sciences, Inc:

• June 1987 – Founded by Michael L. Riordan.
• 1992 – Went public on the NASDAQ.
• 2000s – Became a leading company in HIV treatment with the approval of its first antiretroviral drug.
• 2011 – Acquired Pharmasset, Inc, significantly enhancing its hepatitis C pipeline.
• 2020 – Gained attention for Remdesivir as a treatment for COVID-19.